JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home


*228 !**	Mon, 7/30/2012, 2:00 PM - 3:50 PM	CC-Room 29C
Implementing Bayesian Methods in Drug Development — Topic Contributed Papers
Section on Bayesian Statistical Science , Biopharmaceutical Section , Biometrics Section
Organizer(s): Fanni Natanegara, Eli Lilly and Company
Chair(s): Fanni Natanegara, Eli Lilly and Company
2:05 PM	Use of Bayesian Methods to Assess Probability of Achieving Critical Success Factors (CSFs) in Clinical Trials — Cory Heilmann, Eli Lilly and Company
2:25 PM	Bayesian Implementations in Drug Development: Why Progress Is Slow — Beat Neuenschwander, Novartis Pharma
2:45 PM	Implementing Bayesian Methods in Biological Product Development: Regulatory Perspective and Experience — Boguang Zhen, FDA/CBER
3:05 PM	Discussant: John W. Seaman, PhD, Baylor University
3:25 PM	Discussant: Heinz Schmidli, Novartis Pharma AG
3:45 PM	Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.